Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: April 2025
Date Filed: April 7, 2025
Principal Executive Office: Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, the company likely has no revenue, but this filing does not explicitly state financial figures.
Material Changes
Capital Raise: The filing includes Exhibit 99.1 titled "Completion of Placement," indicating the company has completed a private placement of securities. Specific terms, amounts raised, or number of shares issued are not detailed in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies beyond the completion of the placement.
Investor Verification Checklist
- Review Exhibit 99.1 ("Completion of Placement") for the total amount raised, share price, and number of shares issued.
- Verify the identity of the investors participating in the placement.
- Confirm the intended use of proceeds from the placement.
- Check for any dilution impact on existing shareholders based on the placement size.